{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:01:17Z","timestamp":1790694077802,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2023JJ40920"],"award-info":[{"award-number":["2023JJ40920"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["BX2021382"],"award-info":[{"award-number":["BX2021382"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["GZB20240866"],"award-info":[{"award-number":["GZB20240866"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2021M693571"],"award-info":[{"award-number":["2021M693571"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["NSFC82400873"],"award-info":[{"award-number":["NSFC82400873"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011790","name":"Xiangya Hospital, Central South University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011790","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NSFC82100788"],"award-info":[{"award-number":["NSFC82100788"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NSFC82230023"],"award-info":[{"award-number":["NSFC82230023"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NSFC82400873"],"award-info":[{"award-number":["NSFC82400873"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.isci.2026.115216","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T17:03:11Z","timestamp":1772643791000},"page":"115216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Insufficient erythrocyte-derived S1P: A pathogenic driver and diagnostic biolipid for tumor progression"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1122-0550","authenticated-orcid":false,"given":"Zhenjiang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weilun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhouzhou","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juncheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney E.","family":"Kellems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengzhi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8059-6179","authenticated-orcid":false,"given":"Yang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.115216_bib1","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1001\/jamaoncol.2021.6987","article-title":"Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019","volume":"8","author":"Kocarnik","year":"2022","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.isci.2026.115216_bib2","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.isci.2026.115216_bib3","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3390\/cancers13020338","article-title":"Recent Advances and Future Directions in Clinical Management of Head and Neck Squamous Cell Carcinoma","volume":"13","author":"Muzaffar","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.isci.2026.115216_bib4","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.3390\/biomedicines10092151","article-title":"Immunotherapy in Head and Neck Cancer When, How, and Why?","volume":"10","author":"Pereira","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.isci.2026.115216_bib5","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s40425-019-0662-5","article-title":"The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)","volume":"7","author":"Cohen","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.isci.2026.115216_bib6","doi-asserted-by":"crossref","DOI":"10.1172\/JCI188128","article-title":"Immunotherapeutic strategies in head and neck cancer: Challenges and opportunities","volume":"135","author":"Liu","year":"2025","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.isci.2026.115216_bib7","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1056\/NEJMra1715715","article-title":"Head and Neck Cancer","volume":"382","author":"Chow","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2026.115216_bib8","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","article-title":"Head and neck squamous cell carcinoma","volume":"6","author":"Johnson","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.isci.2026.115216_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.203","article-title":"Hypoxia signaling in cancer: Implications for therapeutic interventions","volume":"4","author":"Zhuang","year":"2023","journal-title":"MedComm"},{"key":"10.1016\/j.isci.2026.115216_bib10","doi-asserted-by":"crossref","first-page":"5703","DOI":"10.3390\/ijms22115703","article-title":"Cancer Cell Metabolism in Hypoxia: Role of HIF-1 as Key Regulator and Therapeutic Target","volume":"22","author":"Infantino","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.115216_bib11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41573-023-00848-6","article-title":"Targeting hypoxia-inducible factors: therapeutic opportunities and challenges","volume":"23","author":"Yuan","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.isci.2026.115216_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.218","article-title":"Metabolic reprogramming in cancer: Mechanisms and therapeutics","volume":"4","author":"Nong","year":"2023","journal-title":"MedComm"},{"key":"10.1016\/j.isci.2026.115216_bib13","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40164-024-00482-x","article-title":"Cancer metabolism and carcinogenesis","volume":"13","author":"Yang","year":"2024","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.isci.2026.115216_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/froh.2020.585710","article-title":"Hypoxic Transformation of Immune Cell Metabolism Within the Microenvironment of Oral Cancers","volume":"1","author":"Chaudhary","year":"2020","journal-title":"Front. Oral Health"},{"key":"10.1016\/j.isci.2026.115216_bib15","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.semcancer.2022.12.011","article-title":"Tumor hypoxia: From basic knowledge to therapeutic implications","volume":"88","author":"Liao","year":"2023","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.isci.2026.115216_bib16","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1080\/14789450.2018.1531710","article-title":"Red blood cells as an organ? How deep omics characterization of the most abundant cell in the human body highlights other systemic metabolic functions beyond oxygen transport","volume":"15","author":"Nemkov","year":"2018","journal-title":"Expert Rev. Proteomics"},{"key":"10.1016\/j.isci.2026.115216_bib17","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1161\/CIRCRESAHA.119.316298","article-title":"Erythrocyte Metabolic Reprogramming by Sphingosine 1-Phosphate in Chronic Kidney Disease and Therapies","volume":"127","author":"Xie","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.isci.2026.115216_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12086","article-title":"Sphingosine-1-phosphate promotes erythrocyte glycolysis and oxygen release for adaptation to high-altitude hypoxia","volume":"7","author":"Sun","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.115216_bib19","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13046-024-02969-1","article-title":"Blood-based biomarkers in patients with non-small cell lung cancer treated with immune checkpoint blockade","volume":"43","author":"Tsai","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.isci.2026.115216_bib20","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejca.2017.12.025","article-title":"The future of blood-based biomarkers for the early detection of breast cancer","volume":"92","author":"Loke","year":"2018","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.isci.2026.115216_bib21","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1053\/j.gastro.2024.03.011","article-title":"Comparative Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening With Blood-Based Biomarkers (Liquid Biopsy) vs Fecal Tests or Colonoscopy","volume":"167","author":"Ladabaum","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.isci.2026.115216_bib22","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3390\/cells12060935","article-title":"Shifting the Cancer Screening Paradigm: The Rising Potential of Blood-Based Multi-Cancer Early Detection Tests","volume":"12","author":"Brito-Rocha","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.isci.2026.115216_bib23","first-page":"1202","article-title":"Erythrocytes store and release sphingosine 1-phosphate in blood","volume":"21","author":"H\u00e4nel","year":"2007","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.isci.2026.115216_bib24","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nature24053","article-title":"Mfsd2b is essential for the sphingosine-1-phosphate export in erythrocytes and platelets","volume":"550","author":"Tm","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.115216_bib25","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/bjc.1995.429","article-title":"Evidence that hypoxia markers detect oxygen gradients in liver: pimonidazole and retrograde perfusion of rat liver","volume":"72","author":"Arteel","year":"1995","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.isci.2026.115216_bib26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.pharmthera.2018.07.006","article-title":"Bioactive lysolipids in cancer and angiogenesis","volume":"193","author":"Hisano","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.isci.2026.115216_bib27","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1146\/annurev-pathol-050420-025929","article-title":"Lysophospholipid mediators in health and disease","volume":"17","author":"Kano","year":"2022","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.isci.2026.115216_bib28","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/s41580-024-00742-y","article-title":"Regulation of cellular and systemic sphingolipid homeostasis","volume":"25","author":"Kuo","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.isci.2026.115216_bib29","doi-asserted-by":"crossref","DOI":"10.1172\/JCI159839","article-title":"Hypoxia-inducible factors: Cancer progression and clinical translation","volume":"132","author":"Wicks","year":"2022","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.isci.2026.115216_bib30","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","article-title":"Hypoxic microenvironment in cancer: Molecular mechanisms and therapeutic interventions","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.isci.2026.115216_bib31","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.immuni.2023.06.017","article-title":"Hypoxic niches attract and sequester tumor-associated macrophages and cytotoxic T cells and reprogram them for immunosuppression","volume":"56","author":"Sattiraju","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2026.115216_bib32","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.semcancer.2023.11.008","article-title":"Hypoxia as a potential inducer of immune tolerance, tumor plasticity and a driver of tumor mutational burden: Impact on cancer immunotherapy","volume":"97","author":"Abou Khouzam","year":"2023","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.isci.2026.115216_bib33","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1097\/SLA.0000000000002431","article-title":"The Allosteric Hemoglobin Effector ITPP Inhibits Metastatic Colon Cancer in Mice","volume":"266","author":"Limani","year":"2017","journal-title":"Ann. Surg."},{"key":"10.1016\/j.isci.2026.115216_bib34","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1038\/s41467-021-24069-w","article-title":"Phase Ib dose-escalation study of the hypoxia-modifier Myo-inositol trispyrophosphate in patients with hepatopancreatobiliary tumors","volume":"12","author":"Schneider","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.115216_bib35","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3390\/jpm11080756","article-title":"Effects of Inositol Hexaphosphate and Myo-Inositol Administration in Breast Cancer Patients during Adjuvant Chemotherapy","volume":"11","author":"Amabile","year":"2021","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.isci.2026.115216_bib36","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1038\/sj.bjc.6603169","article-title":"Efaproxiral red blood cell concentration predicts efficacy in patients with brain metastases","volume":"94","author":"Stea","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.isci.2026.115216_bib37","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1517\/13543784.13.5.543","article-title":"Efaproxiral: A novel radiation sensitiser","volume":"13","author":"Suh","year":"2004","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.isci.2026.115216_bib38","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.3390\/molecules28052050","article-title":"Resveratrol, a New Allosteric Effector of Hemoglobin, Enhances Oxygen Supply Efficiency and Improves Adaption to Acute Severe Hypoxia","volume":"28","author":"Chu","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.isci.2026.115216_bib39","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1007\/s10895-007-0220-2","article-title":"Transport of a cancer chemopreventive polyphenol, resveratrol: interaction with serum albumin and hemoglobin","volume":"17","author":"Lu","year":"2007","journal-title":"J. Fluoresc."},{"key":"10.1016\/j.isci.2026.115216_bib40","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3390\/cells9020337","article-title":"Sphingosine-1-Phosphate in the Tumor Microenvironment: A Signaling Hub Regulating Cancer Hallmarks","volume":"9","author":"Riboni","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.isci.2026.115216_bib41","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrc.2017.96","article-title":"Sphingolipid metabolism in cancer signalling and therapy","volume":"18","author":"Ogretmen","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.isci.2026.115216_bib42","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1021\/acs.jcim.8b00931","article-title":"In silico characterization of structural distinctions between isoforms of human and mouse sphingosine kinases for accelerating drug discovery","volume":"59","author":"Worrell","year":"2019","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.isci.2026.115216_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.683767","article-title":"The functional role of sphingosine kinase 2","volume":"8","author":"Diaz Escarcega","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.isci.2026.115216_bib44","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1042\/BJ20110817","article-title":"SPHINGOSINE KINASE TYPE 1 INHIBITION REVEALS RAPID TURNOVER OF CIRCULATING SPHINGOSINE 1-PHOSPHATE","volume":"440","author":"Kharel","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.isci.2026.115216_bib45","article-title":"Anti-ceramide antibody and sphingosine-1-phosphate as potential biomarkers of unresectable non-small cell lung cancer","volume":"30","author":"B\u0171di","year":"2024","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.isci.2026.115216_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413367","article-title":"Plasma Sphingosine-1-Phosphate Levels Are Associated with Progression of Estrogen Receptor-Positive Breast Cancer","volume":"22","author":"Ikarashi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.115216_bib47","doi-asserted-by":"crossref","first-page":"18095","DOI":"10.18632\/oncotarget.7741","article-title":"Serum sphingolipidomic analyses reveal an upregulation of C16-ceramide and sphingosine-1-phosphate in hepatocellular carcinoma","volume":"7","author":"Grammatikos","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.isci.2026.115216_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109368","article-title":"SPNS2 enables T cell egress from lymph nodes during an immune response","volume":"36","author":"Okuniewska","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2026.115216_bib49","doi-asserted-by":"crossref","first-page":"7697","DOI":"10.1021\/acs.jmedchem.2c00040","article-title":"Novel Sphingosine Kinase 1 Inhibitor Suppresses Growth of Solid Tumor and Inhibits the Lung Metastasis of Triple-Negative Breast Cancer","volume":"65","author":"Zhang","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.isci.2026.115216_bib50","doi-asserted-by":"crossref","first-page":"7199","DOI":"10.7150\/thno.102390","article-title":"SPHK1 promotes HNSCC immune evasion by regulating the MMP1-PD-L1 axis","volume":"14","author":"Fang","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.isci.2026.115216_bib51","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1158\/0008-5472.CAN-18-3803","article-title":"Sphingosine Kinase 1 Signaling Promotes Metastasis of Triple-Negative Breast Cancer","volume":"79","author":"Acharya","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2026.115216_bib52","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41467-019-14218-7","article-title":"Resistance of melanoma to immune checkpoint inhibitors is overcome by targeting the sphingosine kinase-1","volume":"11","author":"Imbert","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.115216_bib53","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/s41423-022-00911-z","article-title":"Sphingosine kinase 1 promotes tumor immune evasion by regulating the MTA3-PD-L1 axis","volume":"19","author":"Lau","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.isci.2026.115216_bib54","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1126\/science.1139221","article-title":"Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate","volume":"316","author":"Pappu","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.isci.2026.115216_bib55","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nature02284","article-title":"Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1","volume":"427","author":"Matloubian","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.115216_bib56","doi-asserted-by":"crossref","first-page":"15635","DOI":"10.18632\/oncotarget.24583","article-title":"Deletion of sphingosine kinase 1 inhibits liver tumorigenesis in diethylnitrosamine-treated mice","volume":"9","author":"Chen","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.isci.2026.115216_bib57","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/archotol.133.5.495","article-title":"The role of human papilloma virus 16 E6 in anchorage independent and invasive growth of tonsil epithelium","volume":"133","author":"Hoover","year":"2007","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.isci.2026.115216_bib58","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/s41597-023-02611-3","article-title":"Characterization of immune microenvironment in patients with HPV-positive and negative head and neck cancer","volume":"10","author":"Wang","year":"2023","journal-title":"Sci. Data"},{"key":"10.1016\/j.isci.2026.115216_bib59","doi-asserted-by":"crossref","DOI":"10.2217\/ijr.13.40","article-title":"Sphingosine kinase and sphingosine-1-phosphate: regulators in autoimmune and inflammatory disease","volume":"8","author":"Snider","year":"2013","journal-title":"Int. J. Clin. Rheumtol."},{"key":"10.1016\/j.isci.2026.115216_bib60","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12964-024-01626-6","article-title":"Signaling controversy and future therapeutical perspectives of targeting sphingolipid network in cancer immune editing and resistance to tumor necrosis factor-\u03b1 immunotherapy","volume":"22","author":"Sukocheva","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.isci.2026.115216_bib61","doi-asserted-by":"crossref","first-page":"R67","DOI":"10.1186\/bcr3174","article-title":"Early vascular deficits are correlated with delayed mammary tumorigenesis in the MMTV-PyMT transgenic mouse following genetic ablation of the NG2 proteoglycan","volume":"14","author":"Gibby","year":"2012","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.isci.2026.115216_bib62","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1681\/ASN.0000000000000195","article-title":"Erythrocyte ENT1-AMPD3 axis is an essential purinergic hypoxia sensor and energy regulator combating CKD in a mouse model","volume":"34","author":"Chen","year":"2023","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.isci.2026.115216_bib63","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/978-1-4939-9236-2_19","article-title":"El-MAVEN: A fast, robust, and user-friendly mass spectrometry data processing engine for metabolomics","volume":"1978","author":"Agrawal","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.isci.2026.115216_bib64","doi-asserted-by":"crossref","first-page":"W398","DOI":"10.1093\/nar\/gkae253","article-title":"MetaboAnalyst 6.0: Towards a unified platform for metabolomics data processing, analysis and interpretation","volume":"52","author":"Pang","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2026.115216_bib65","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ab.2003.11.018","article-title":"Fluorescence-based assay of sphingosine kinases","volume":"326","author":"Billich","year":"2004","journal-title":"Anal. Biochem."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226005912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226005912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:38:27Z","timestamp":1790692707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226005912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2589004226005912"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.115216","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insufficient erythrocyte-derived S1P: A pathogenic driver and diagnostic biolipid for tumor progression","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.115216","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115216"}}